Sathgen Therapeutics completes dosing of the first two cohorts of healthy volunteers with MSP008-22, a novel anti-viral drug ...Middle East

MSP008-22 is a new drug candidate that shows excellent efficacy against a range of viruses during preclinical development MUMBAI, India, Aug. 9, 2023 /PRNewswire/ -- Sathgen Therapeutics, a division of the leading chemicals conglomerate in India – Godavari Biorefineries Limited (GBL),...

Hence then, the article about sathgen therapeutics completes dosing of the first two cohorts of healthy volunteers with msp008 22 a novel anti viral drug was published today ( Wednesday 09/08/2023 - 10:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sathgen Therapeutics completes dosing of the first two cohorts of healthy volunteers with MSP008-22, a novel anti-viral drug )

Also on site :

• As Colorado’s wildfire threat grows, Douglas County turns to biochar as ‘next level’ mitigation tool
• One of NYC’s Most Unexpected New Attractions Is Under Times Square
• Carhartt’s 'Cozy' Pullover Is 'Perfect for Cold Weather' and It’s on Sale for $28